Stock Analysis on Net
Stock Analysis on Net

Elevance Health Inc. (NYSE:ELV)

$24.99

Analysis of Liquidity Ratios
Quarterly Data

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check

Liquidity Ratios (Summary)

Elevance Health Inc., liquidity ratios (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Current ratio
Quick ratio
Cash ratio

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The liquidity profile of the organization demonstrates consistent stability and a gradual strengthening of short-term solvency over the analyzed period from March 2022 through June 2026. All three primary liquidity metrics remained above critical thresholds, indicating a sustained capacity to meet short-term obligations as they fall due.

Current Ratio
The current ratio maintained a steady upward trajectory, starting at 1.36 in March 2022 and concluding at 1.52 in June 2026. A period of notable growth is observed between March 2024 and September 2025, during which the ratio peaked at 1.56. This indicates a systematic increase in the margin of safety regarding current assets relative to current liabilities.
Quick Ratio
The quick ratio mirrors the movement of the current ratio, beginning at 1.23 and ending at 1.38. The narrow variance between the current and quick ratios suggests that the organization maintains a minimal concentration of less liquid current assets, such as inventory. The highest liquidity peak occurred in September 2025 at 1.43, aligning with the peak of the current ratio.
Cash Ratio
The cash ratio exhibited greater volatility compared to the broader liquidity measures, fluctuating between a low of 0.79 in early 2025 and a peak of 0.92 in June 2023. Despite these fluctuations, the ratio remained relatively high, generally staying within the 0.80 to 0.90 range. A temporary dip in liquidity is noted in the first half of 2025, followed by a recovery to 0.85 by June 2026.

Overall, the correlation between the current and quick ratios suggests a high quality of current assets. The consistency of these ratios, combined with a cash ratio that frequently approaches 0.90, reflects a conservative liquidity management strategy and a strong immediate ability to cover liabilities without relying on the sale of assets.



Current Ratio

Elevance Health Inc., current ratio calculation (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Current assets
Current liabilities
Liquidity Ratio
Current ratio1
Benchmarks
Current Ratio, Competitors2
Abbott Laboratories
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q2 2026 Calculation
Current ratio = Current assets ÷ Current liabilities
= ÷ =

2 Click competitor name to see calculations.


The liquidity position of the organization demonstrates a consistent strengthening trend over the analyzed period from March 2022 through June 2026. Short-term solvency has remained stable, with the organization maintaining a current ratio consistently above 1.30, indicating a sustained ability to meet short-term obligations using current assets.

Current Asset Trajectory
Current assets exhibited a general upward trend, increasing from 53,897 million US dollars in March 2022 to 67,184 million US dollars by June 2026. While a temporary contraction occurred in December 2024, where assets dipped to 58,942 million US dollars, the overall trajectory reflects a significant expansion of the liquid asset base over the four-year period.
Current Liability Management
Current liabilities remained relatively controlled, fluctuating between a low of 39,308 million US dollars in June 2022 and a peak of 45,309 million US dollars in March 2026. The growth in liabilities occurred at a slower pace than the growth in assets, which contributed to the improvement in the overall liquidity margin.
Current Ratio Analysis
The current ratio moved from a baseline of 1.36 in early 2022 to a peak of 1.56 in September 2025. A period of relative stability was observed throughout 2022 and 2023, with the ratio hovering between 1.35 and 1.44. A more pronounced improvement occurred between March 2024 and September 2025, during which the ratio climbed from 1.37 to 1.56. By mid-2026, the ratio stabilized at 1.52, representing a higher permanent floor of liquidity compared to the 2022 levels.

The observed data suggests a strategic increase in the liquidity buffer. The divergence between the growth rates of current assets and current liabilities indicates an enhanced capacity to absorb short-term financial shocks without compromising operational stability.



Quick Ratio

Elevance Health Inc., quick ratio calculation (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Cash and cash equivalents
Fixed maturity securities
Equity securities
Premium receivables, net
Self-funded receivables, net
Other receivables
Total quick assets
 
Current liabilities
Liquidity Ratio
Quick ratio1
Benchmarks
Quick Ratio, Competitors2
Abbott Laboratories
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q2 2026 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= ÷ =

2 Click competitor name to see calculations.


The analysis of liquidity over the period from March 31, 2022, to June 30, 2026, indicates a consistent and strengthening capacity to meet short-term obligations using highly liquid assets. The quick ratio remained above 1.0 throughout the entire duration, signifying that the entity maintains sufficient liquid assets to cover its current liabilities without relying on the sale of inventory.

Total Quick Assets Trend
A sustained upward trajectory in total quick assets is observed, growing from 48,704 million US dollars in March 2022 to 60,906 million US dollars by June 2026. A notable increase occurred between December 31, 2022, and March 31, 2023, where assets rose from 50,336 million to 54,880 million US dollars. Following this jump, quick assets generally stabilized above the 53,000 million US dollar threshold, peaking at 60,906 million US dollars in the final quarter of the observed period.
Current Liabilities Management
Current liabilities exhibited relative stability with moderate growth over the analyzed timeframe. Starting at 39,733 million US dollars in March 2022, liabilities reached 44,254 million US dollars by June 2026. While there were periodic fluctuations—such as a decrease to 40,581 million US dollars in September 2024—the overall growth in liabilities was outpaced by the growth in quick assets, contributing to an improved liquidity position.
Quick Ratio Performance
The quick ratio fluctuated within a healthy range of 1.21 to 1.43. The ratio reached its lowest point of 1.21 in September 2022 before trending generally upward. A peak efficiency in liquidity was recorded on September 30, 2025, with a ratio of 1.43. By June 30, 2026, the ratio stood at 1.38, reflecting a strong margin of safety and a robust short-term financial position compared to the 2022 baseline of 1.23.

In summary, the financial position is characterized by increasing liquidity reserves and disciplined management of short-term liabilities. The expansion of the quick ratio over the multi-year period suggests a deliberate strengthening of the balance sheet to ensure immediate solvency and operational flexibility.



Cash Ratio

Elevance Health Inc., cash ratio calculation (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Cash and cash equivalents
Fixed maturity securities
Equity securities
Total cash assets
 
Current liabilities
Liquidity Ratio
Cash ratio1
Benchmarks
Cash Ratio, Competitors2
Abbott Laboratories
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q2 2026 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= ÷ =

2 Click competitor name to see calculations.


The liquidity profile exhibits a consistent pattern of stability with periodic fluctuations in the cash ratio, which remained within a range of 0.79 to 0.92 over the analyzed period. While total cash assets and current liabilities both showed volatility, the relationship between the two indicates a disciplined approach to maintaining short-term solvency.

Cash Asset Trends
Total cash assets fluctuated between a low of 33,652 million US dollars in December 2023 and a peak of 38,895 million US dollars in September 2023. A period of growth was observed through the first three quarters of 2023, followed by a general stabilization phase between 2024 and 2026, where balances typically remained between 34,000 and 37,000 million US dollars.
Current Liabilities Analysis
Current liabilities demonstrated a gradual upward trajectory over the long term. Starting at 39,733 million US dollars in March 2022, obligations rose to a peak of 45,309 million US dollars by March 2026. This expansion in short-term liabilities suggests an increase in operating obligations or a shift in short-term financing strategies.
Cash Ratio Volatility
The cash ratio reached its highest point of 0.92 in June 2023, indicating a strong ability to cover nearly all current liabilities with cash on hand. Conversely, the ratio declined to its lowest levels of 0.79 during the first half of 2025. This dip coincided with a simultaneous increase in current liabilities and a relative decrease in total cash assets. By June 2026, the ratio settled at 0.85, returning to the baseline levels observed at the start of the period.
Liquidity Correlation
The data indicates that the cash ratio is more sensitive to changes in current liabilities than to fluctuations in cash assets. For instance, the decline in the ratio during early 2025 was driven primarily by liabilities exceeding 42,000 million US dollars while cash assets remained below 35,000 million US dollars. The recovery observed in late 2025 was supported by a reduction in current liabilities to approximately 40,878 million US dollars alongside a recovery in cash holdings.